Back to search

Poland· PL-100116857

Dianeal PD4 (glukoza 2,27%). Zestaw do dializy otrzewnowej

A peritoneal dialytics product containing produkt złożony, registered in Poland by Vantive Belgium SRL. The same ATC class is registered in 3 of our 19 countries.

ATC B05D

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDianeal PD4 (glukoza 2,27%). Zestaw d…ATCB05DREGISTER NO.PL-100116857PACKS LISTED19CHECKEDSeptember 27, 2026

Where it is registered

Produkt złożony is registered in 3 of 19 countries.

Countries holding a registration under ATC B05D (peritoneal dialytics), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Produkt złożony · ATC B05D

3 / 19 countries

  • Denmark
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Produkt złożony
Manufacturer
Vantive Belgium SRL
Country
Poland (PL)
ATC code
B05D
ATC class
PERITONEAL DIALYTICS
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 19

  • gtin
    05909991300364
  • gtin
    05909991300371
  • gtin
    05909991300357
  • gtin
    05909991300319
  • gtin
    05909991300326
  • gtin
    05909991300333
  • gtin
    05909991300340
  • gtin
    05909991300388
  • gtin
    05909991300395
  • gtin
    05909990857593
  • gtin
    05909990857609
  • gtin
    05909990857623
  • gtin
    05909990857630
  • gtin
    05909990857647
  • gtin
    05909990905263
  • gtin
    05909990905270
  • gtin
    05909990905287
  • gtin
    05909990905294
  • gtin
    05909991413569

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/12c4f4b5-bb68-45d8-81de-6200d28b5196
GET /v1/drugs/12c4f4b5-bb68-45d8-81de-6200d28b5196?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do dializy otrzewnowej",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909991300357 ¦ Lz ¦ 21509\n1 poj. 1500 ml\n05909991300319 ¦ Lz ¦ 21540\n1 poj. 250 ml\n05909991300326 ¦ Lz ¦ 21542\n1 poj. 500 ml\n05909991300333 ¦ Lz ¦ 21544\n1 poj. 750 ml\n05909991300340 ¦ Lz ¦ 21545\n1 poj. 1000 ml\n05909991300364 ¦ Lz ¦ 21547\n1 poj. 2000 ml\n05909991300371 ¦ Lz ¦ 21548\n1 poj. 2500 ml\n05909991300388 ¦ Lz ¦ 21549\n1 poj. 3000 ml\n05909991300395 ¦ Lz ¦ 21550\n1 poj. 5000 ml\n05909990857593 ¦ Lz ¦ 65622\n6 poj. 1500 ml\n05909990857609 ¦ Lz ¦ 65623\n5 poj. 2000 ml\n05909990857623 ¦ Lz ¦ 65626\n4 poj. 2500 ml\n05909990857630 ¦ Lz ¦ 65627\n3 poj. 3000 ml\n05909990857647 ¦ Lz ¦ 65628\n2 poj. 5000 ml\n05909990905263 ¦ Lz ¦ 69640\n6 poj. 2000 ml\n05909990905270 ¦ Lz ¦ 69641\n8 poj. 2000 ml\n05909990905287 ¦ Lz ¦ 69642\n4 poj. 3000 ml Viaflex\n05909990905294 ¦ Lz ¦ 69643\n4 poj. 5000 ml\n05909991413569 ¦ Lz ¦ 133986\n4 poj. 2500 ml",
  "substance": "Natrii chloridum 5.38 mg + Natrii lactas 4.48 mg + Glucosum 38.6 mg + Calcii chloridum dihydricum 0.184 mg + Magnesii chloridum hexahydricum 0.051 mg",
  "common_name": "Produkt złożony",
  "pl_product_id": "100116857",
  "pozwolenie_nr": "13003",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about produkt złożony.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.